https://www.israelhealthcarenews.com/article/913439295-fitch-upgrades-teva-to-investment-grade-amid-pivot-to-growth-execution Israel Healthcare News en PressRelease 2026-05-18T12:30:00+00:00 Fitch Upgrades Teva to Investment Grade Amid Pivot to Growth Execution https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.israelhealthcarenews.com/article/913439318-silexion-therapeutics-reports-first-quarter-2026-financial-results-and-provides-business-update Israel Healthcare News en PressRelease 2026-05-18T12:30:00+00:00 Silexion Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update https://ml-eu.globenewswire.com/media/1070dc42-db79-4712-af48-38ffbdf3b140/small/screenshot-2025-05-13-at-15-29-06-png.png https://www.israelhealthcarenews.com/article/913427871-teva-study-finds-only-23-of-younger-adults-with-mood-disorders-and-tardive-dyskinesia-td-symptoms-are-formally-diagnosed-with-td-despite-widespread Israel Healthcare News en PressRelease 2026-05-18T12:00:00+00:00 Teva Study Finds Only 23% of Younger Adults with Mood Disorders and Tardive Dyskinesia (TD) Symptoms Are Formally Diagnosed with TD Despite Widespread Impact https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg https://www.israelhealthcarenews.com/article/913428334-enlivex-announces-dosing-of-first-patient-in-the-united-states-as-part-of-its-phase-2b-trial-of-allocetra-in-age-related-primary-moderate-to-severe Israel Healthcare News en PressRelease 2026-05-18T12:00:00+00:00 Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis https://ml.globenewswire.com/media/27d4e006-8709-4fd1-8341-5b58381487d4/small/picture1-jpg.jpg https://www.israelhealthcarenews.com/article/913428196-brainsway-announces-minority-stake-investment-in-hopemark-health Israel Healthcare News en PressRelease 2026-05-18T11:30:00+00:00 BrainsWay Announces Minority-Stake Investment in Hopemark Health https://ml.globenewswire.com/media/ea01c8f7-39be-46d2-a8e0-bc05994f170e/small/brainsway-2021-logo-jpg.jpg